Sponsor Pipeline

Valneva Austria GmbH Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
0
Recruiting
1
Phase 3
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-22 NCT07254702
Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for…
overall status: Enrolling by Invitation → Active, Not Recruiting
2026-07-21 NCT07414524
VLA1553-403 Pregnancy Surveillance Study
overall status: Not Yet Recruiting → Enrolling by Invitation
2026-07-21 NCT07414524
VLA1553-403 Pregnancy Surveillance Study
Trial sites expanded: 0 -> 3 locations
2026-07-19 NCT04838444
Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)
Primary endpoint(s) modified
Active Trials by Phase
Phase 3
1
Not specified
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04838444 Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553) Chikungunya Virus Infection Active, Not Recruiting
Not specified
NCT07163845 Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the… Chikungunya Virus Infection Active, Not Recruiting
NCT07347002 Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing… Chikungunya Virus Infection Enrolling by Invitation
NCT07414524 VLA1553-403 Pregnancy Surveillance Study Chikungunya Virus Infection Enrolling by Invitation
NCT07254702 Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for… Chikungunya Virus Infection Active, Not Recruiting
Get alerts when Valneva Austria GmbH's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free